Dr. Syed Fahad Iftikhar, MD

Dr. Iftikhar practices at Riverside Medical Clinic - Brockton/Riverside in Riverside, California.

Dr. Iftikhar's NPI, 1730542515, was assigned on March 30, 2016. Dr. Iftikhar holds California license A160234.

Dr. Iftikhar's primary practice is Riverside Medical Clinic - Brockton/Riverside, at 7117 Brockton Ave, Riverside, CA 92506 in Riverside County. The practice phone is (951) 683-6370.

Dr. Iftikhar's primary practice is Riverside Medical Clinic - Brockton/Riverside in Riverside, California. Dr. Iftikhar is also affiliated with Riverside Community Hospital. The medical group on file is Riverside Medical Clinic. Dmand AI also links Dr. Iftikhar to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iftikhar practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Iftikhar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Iftikhar is licensed in California.

CMS data shows 160 Medicare services from Dr. Iftikhar across 6 procedure codes in 2024, for 95 Medicare patients. Medicare paid $9,712 for them.

CMS counts 95 Medicare patients who saw Dr. Iftikhar in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iftikhar's median patient age at 69, with 53% women.

In 2024, Dr. Iftikhar wrote 90 Medicare Part D claims for 47 patients. 80% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $55 in total drug cost. In 2020, CMS named 47 claims across 4 drugs.

Dr. Iftikhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Iftikhar as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Iftikhar, published from 2019 to 2021. 2019 was the busiest year, with 3. Dr. Iftikhar has published most often in Cardiol Res. Dr. Iftikhar's most frequent co-authors are Javad Savoj, Patrick Pei-Chih Hu, MD, PhD and Asma Jamil, MD.

CMS Open Payments shows 77 general payments to Dr. Iftikhar from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 95% of the total. Abiomed paid the most, $1,134. It also lists 2 research payments totaling $91 in 2024.